About the Authors

Hana Kammoun

Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France

Xavier Roux

Current address: Tolerys Biolabs SAS, Bâtiment le Forum 2, Archamps Technopôle, Archamps, France

Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France

Dominique Raze

Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France

Anne-Sophie Debrie

Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France

Marina De Filette

Current address: Laboratory of Gene Therapy, Faculty of Veterinary Sciences, Ghent University, Merelbeke, Belgium

Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium

Tine Ysenbaert

Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium

Nathalie Mielcarek

Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France

Xavier Saelens

Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium

Walter Fiers

Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium

Camille Locht

camille.locht@pasteur-lille.fr

Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France

Competing Interests

The authors have read the journal’s policy and have the following conflicts. Several patents have been applied on the recombinant attenuated B. pertussis strains, as well as on M2e as a potential vaccine antigen. These patent rights are owned by the institutions to which the authors are affiliated. Although a small part of the work (M2e-VLP construction) was done in collaboration with SanofiPasteur, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: XS WF CL. Performed the experiments: HK XR DR ASD MDF TY. Analyzed the data: HK NM XS WF CL. Wrote the paper: HK XS CL.